Replies to post #1491 on Vascular Biogenics Ltd (VBLT)

[Jumpinjackas]

We are not talking about avg -vs- median. I learned that long ago, but thank you!


You are saying at 12 mos, the patients on VB-111 will show much greater difference compared to Avastin only arm.

When looking at the overall survival, (survival probablity vs time to death)..VB-111 will close to Avastin only arm.

Do you know how that sounds?

If you want to keep it simple, then give me a number.

12 mos: VB-111 x% (meaning what % are live at 12 mos after starting infusion)


MOS: what is the median survival number.. Xmos

Have at it professor.